Quick Takeaways
- WELLINGTON MANAGEMENT GROUP LLP filed SCHEDULE 13G/A for PTC Therapeutics, Inc. Common Stock (PTCT).
- Disclosed ownership: 6.2%.
- Date of event: 31 Dec 2024.
WELLINGTON MANAGEMENT GROUP LLP - 31 Dec 2024 SCHEDULE 13G/A Report for PTC Therapeutics, Inc. Common Stock (PTCT)
- Filing Manager
- WELLINGTON MANAGEMENT GROUP LLP
- Reporting Manager
- Wellington Management Group LLP
- Security
- PTC Therapeutics, Inc. Common Stock
- Symbol
- PTCT
- Shares outstanding
- 77,211,661 shares
- Disclosed Ownership
- 4,787,123 shares
- Ownership
- 6.2%
- Form type
- SCHEDULE 13G/A
- Filing time
- 10 Feb 2025, 10:25:37 UTC
- Date of event
- 31 Dec 2024
- Next filing
- 10 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"WELLINGTON MANAGEMENT GROUP LLP disclosed 6.2% ownership in PTC Therapeutics, Inc. Common Stock (PTCT) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 10 Feb 2025, 10:25.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Wellington Management Group LLP | 6.2% | 4,787,123 | 0 | 4,530,210 | Taisia Lowe | Regulatory Analyst | |
| Wellington Group Holdings LLP | 6.2% | 4,787,123 | 0 | 4,530,210 | Taisia Lowe | Regulatory Analyst | |
| Wellington Investment Advisors Holdings LLP | 6.2% | 4,787,123 | 0 | 4,530,210 | Taisia Lowe | Regulatory Analyst | |
| Wellington Management Company LLP | 6.1% | 4,787,123 | 0 | 4,505,920 | Taisia Lowe | Regulatory Analyst |